Author Question: An unresponsive patient is breathing at a rate of 6 breaths per minute. What intervention would be ... (Read 44 times)

lbcchick

  • Hero Member
  • *****
  • Posts: 550
An unresponsive patient is breathing at a rate of 6 breaths per minute. What intervention would be most beneficial for the patient?
 
  A) Positive pressure ventilation with O2 a rate of 30 and tidal volume of 200 mL
  B) Oxygen at 15 liters per minute delivered through a nonrebreather face mask
  C) Positive pressure ventilation with a rate of 12 and tidal volume of 500 mL
  D) Oral airway and positive pressure ventilation at 40 per minute, supplemental O2, and volume of 100

Question 2

Arteries carry primarily ________ blood away from the heart, while veins primarily carry ________ blood back to the heart.
 
  A) deoxygenated / oxygenated B) hypoglycemic / hyperglycemic
  C) whole / plasma D) oxygenated / deoxygenated



chevyboi1976

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

C

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library